Cellesce is a biotechnology company that has developed proprietary (patent pending) bioprocessing technology for the growing on and expansion of organoids. Cellesce aims to become a leading contract research organisation focused on the supply of standardised and well characterised cancer organoids for large-scale applications such as compound screening, especially for high throughput screening requirement, where significant quantities of reproducible batches are required.
The Cellesce team is based in state-of-the-art laboratory space in Cardiff. Cellesce operates according to the highest ethical standards to ensure appropriate confidentiality and regulatory requirements.
Cellesce Ltd news articles
6 September 2018
Cellesce and Cardiff University win Innovate UK Primer Award to develop Organoids at scale to advance Breast Cancer Research